Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,768 public trials 494 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2

NCT01419639

Conditions: Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, +35 more
Locations: New York University Medical Center New York, United States

View Trial Details

Completed

Infrared Lymphangiography as a Method of Sentinel Node Identification

NCT02057393

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: Penn State Milton S. Hershey Medical Center Hershey, Pennsylvania, United States

View Trial Details

Completed

Genetic Analysis of Familial Melanoma

NCT00339404

Conditions: Melanoma, Melanoma, Cutaneous Malignant, Neoplasms, +10 more
Locations: National Human Genome Research Institute (NHGRI), 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Cyclophosphamide and Fludarabine Followed By Interleukin-2 Gene-Modified Tumor Infiltrating Lymphocytes in Treating Patients With Metastatic Melanoma

NCT00062036

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States

NCI - Center for Cancer Research Bethesda, Maryland, United States

View Trial Details

Completed

Cinacalcet to Treat Familial Primary Hyperparathyroidism

NCT00325104

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +34 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Microarray Analysis for Human Genetic Disease

NCT00001898

Conditions: Adnexal Diseases, Breast Diseases, Breast Neoplasm, +30 more
Locations: Arizona Cancer Center Tucson, Arizona, United States

Johns Hopkins University Baltimore, Maryland, United States

University of Michigan Ann Arbor, Michigan, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

131MIBG to Treat Malignant Pheochromocytoma

NCT00028106

Conditions: Neoplasm Metastasis, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

A Study of TBI-1401(HF10) in Patients With Solid Tumors With Superficial Lesions

NCT02428036

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: National Cancer Center Hospital Chuo-ku, Tokyo, Japan

View Trial Details

Completed

An Observational Study of BRAF Inhibitors Effectiveness in Patients With Newly Diagnosed Metastatic Melanoma

NCT02143999

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: Policlinico Ospedaliero Ss Annunziata; U.O. Di Clinica Oncologica Chieti, Abruzzo, Italy

Istituto Tumori Giovanni Paolo II IRCCS Ospedale Oncologico Bari Bari, Apulia, Italy

IRCCS IST. Tumori Fondaz. Pascale; S.C. Oncologia Medica,Melanoma,Immunoterapia E Terapie Innovative Naples, Campania, Italy

Azienda Ospedaliero-Universitaria S.Orsola-Malpighi; Unità Operativa Oncologia Medica Bologna, Emilia-Romagna, Italy

View all 24 locations

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

NCT00471471

Conditions: Eye Diseases, Eye Neoplasms, Intraocular Melanoma, +17 more
Locations: UPMC Cancer Centers Pittsburgh, Pennsylvania, United States

View Trial Details

Neuroendocrine Tumors

Neuroendocrine Tumors trial results

Related conditions